
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license research and collaborat... Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single in-office intravitreal IVT injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust sustained treatment response reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor VEGF injections. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.53 | -18.7943262411 | 2.82 | 2.82 | 2.285 | 150828 | 2.49953327 | CS |
4 | -0.23 | -9.12698412698 | 2.52 | 3.1 | 2.1 | 180397 | 2.50325599 | CS |
12 | -2.55 | -52.6859504132 | 4.84 | 5.23 | 1.78 | 350577 | 2.90195868 | CS |
26 | -2.98 | -56.5464895636 | 5.27 | 5.7237 | 1.78 | 263704 | 3.47931808 | CS |
52 | -4.99 | -68.543956044 | 7.28 | 10.14 | 1.78 | 260630 | 5.37250508 | CS |
156 | -7.81 | -77.3267326733 | 10.1 | 29.8 | 1.78 | 563421 | 12.74005447 | CS |
260 | -239.41 | -99.0525444766 | 241.7 | 269.8 | 1.78 | 940403 | 40.97771128 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions